Treatment of Advanced Non-Small Cell Luna Cancer in 2018

被引：88
作者：
Doroshow, Deborah B. [1 ]
Herbst, Roy S. [1 ]
机构：
[1] Yale Canc Ctr, 333 Cedar St,POB 208028, New Haven, CT 06520 USA
来源：
JAMA ONCOLOGY | 2018年 / 4卷 / 04期
关键词：
PHASE-III; PEMBROLIZUMAB; CHEMOTHERAPY; OSIMERTINIB; CARBOPLATIN;
D O I：
10.1001/jamaoncol.2017.5190
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：569 / 570
页数：2
相关论文
共 50 条
  • [1] A Paradigm Shift in the Treatment of Advanced Non-Small Cell Lung Cancer
    Varughese, Shibu
    Jahangir, K. Saad
    Simpson, Catherine E.
    Boulmay, Brian C.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2012, 344 (02) : 147 - 150
  • [2] Implementation of immunotherapy in the treatment of advanced non-small cell lung cancer (NSCLC)
    Tsiara, Anna
    Liontos, Michalis
    Kaparelou, Maria
    Zakopoulou, Roubini
    Bamias, Aristotelis
    Dimopoulos, Meletios-Athanasios
    ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6 (08)
  • [3] Treatment Toxicity in Elderly Patients With Advanced Non-Small Cell Lung Cancer
    Kale, Minal S.
    Mhango, Grace
    Gomez, Jorge E.
    Sigel, Keith
    Smith, Cardinale B.
    Bonomi, Marcelo
    Wisnivesky, Juan P.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2017, 40 (05): : 470 - 476
  • [4] The treatment of advanced non-small cell lung cancer
    Spiro, SG
    Silvestri, GA
    CURRENT OPINION IN PULMONARY MEDICINE, 2005, 11 (04) : 287 - 291
  • [5] Novel immunotherapy in the treatment of advanced non-small cell lung cancer
    Santabarbara, G.
    Maione, P.
    Rossi, A.
    Palazzolo, G.
    Gridelli, C.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (12) : 1571 - 1581
  • [6] CRIZOTINIB FOR THE TREATMENT OF PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    Bowles, D. W.
    Weickhardt, A. J.
    Doebele, R. C.
    Camidge, D. R.
    Jimeno, A.
    DRUGS OF TODAY, 2012, 48 (04) : 271 - 282
  • [7] Immunotherapy in treatment naive advanced non-small cell lung cancer
    Ernani, Vinicius
    Ganti, Apar Kishor
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S412 - S421
  • [8] Advances in treatment for non-small cell lung cancer
    Price, Katharine A.
    Jett, James R.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2010, 14 (07) : 792 - 794
  • [9] Osimertinib for the treatment of non-small cell lung cancer
    Sun, Jong-Mu
    Lee, Se-Hoon
    Ahn, Jin Seok
    Park, Keunchil
    Ahn, Myung-Ju
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (02) : 225 - 231
  • [10] Impact of renal function on treatment options and outcomes in advanced non-small cell lung cancer
    Cenik, Bercin Kutluk
    Sun, Han
    Gerber, David E.
    LUNG CANCER, 2013, 80 (03) : 326 - 332
12345